We are pioneering continuous lactate monitoring, giving clinicians and consumers a real-time view of whether the body has enough oxygen.
Heart rate, pulse oximetry and sleep. Wearables made the body's rhythms part of everyday life.
Continuous glucose monitoring showed that body chemistry can be measured on the body, every minute of the day.
The chemistry of oxygen, added to the signals wearables already capture.
Diet, metabolism, diabetes
Exercise, cardiovascular fitness, critical illness, trauma
Lactate tells us whether our cells and organs are getting enough oxygen. The same sensor platform serves both.
A live view of the baby's oxygen during labor.
Continuous lactate in place of repeated blood draws.
Tissue oxygen tracked through surgery and recovery.
Lactate threshold, the gold standard behind training zones, measured directly.
A chemical view of how the heart handles workload over time.
Clinical-grade chemistry on the body, built toward early warning of bleeding and infection.
DelivAssure is our first in-hospital product, and the first continuous lactate sensor proven in childbirth. It gives clinicians a live view of the baby's lactate throughout labor, alongside the heart rate they already monitor.
%20(1).png)
A single-use sensor built into the fetal scalp electrode clinicians already apply.
A wireless unit worn on the leg, so mothers stay free to move.
A bedside display with a number and a threshold clinicians can act on.
DelivAssure is an investigational device. It is not cleared or approved by the FDA and is not available for sale.
Birth is the most dangerous day of our lives. In labor, clinicians need to know one thing: is the baby getting enough oxygen?
Today they answer it with fetal heart rate monitoring. Heart rate is an indirect signal, and on its own it fails us.
It leads to misdiagnosis in both directions. Babies who need intervention can be missed, and many mothers go through C-sections they didn't need.
DelivAssure measures lactate, the direct answer to the question clinicians are asking.
Measures lactate, the direct signal of whether the baby is getting enough oxygen.
A live reading throughout labor, in place of a single blood sample.
A clear number and threshold, so decisions are made on evidence.
Accurate out of the box, with no blood calibration before use.
Applied the same way as the fetal scalp electrode clinicians already use.
Designed to leave mothers free to move during labor.
Our approach is built on three interconnected pillars.
We design factory-calibrated electrochemical sensors on the same principles as continuous glucose monitors, and make them in-house at our facilities in Australia, on a process built to scale.
We prove our sensors where measurement is hardest. Our first results in labor are published, and DelivAssure holds FDA Breakthrough Device designation on its path through De Novo.
Every sensor records lactate alongside heart rate and what happened to the patient. Wearables know what healthy looks like. We'll know what sick looks like, and build the chemical dataset the next generation of health AI will learn from.
Dr Arjun KaushikFounder & CEOMedicine, University of Western Australia · Perth Biodesign
Dr Lee HubbleChief Scientific OfficerFormer Senior Research Scientist, CSIRO · Faculty affiliate, UC San Diego
Dr Julian ShapleyChief Operating OfficerCo-founder, Cellnovo · Founder, Glucose Republic
Prof. Jonathan Morris AMChief Medical OfficerProfessor of Obstetrics, University of Sydney · Former Director, Kolling Institute
Dr Amy PollackNon-Executive DirectorFormer Director, Maternal, Newborn and Child Health, Gates Foundation · Former Medtronic executive
Julian SuttonNon-Executive DirectorCFO and Executive Director, 4DMedical (ASX: 4DX)
John LivingstonBoard ObserverFormer CEO, Integral Diagnostics · Executive Director, 4DMedical
Prof. George SaadeMaternal-fetal medicineChair of OB-GYN, EVMS · Past president, SMFM
Prof. Sean BlackwellMaternal-fetal medicineChair of OB-GYN, UTHealth Houston · Past president, SMFM
Prof. Christoph LeesFetal medicineProfessor of Obstetrics, Imperial College London"This is a quantum leap."Prof. George Saade, past president, Society for Maternal-Fetal Medicine
Wearables digitized the body's physics. We're digitizing its chemistry, starting with lactate.
